139 related articles for article (PubMed ID: 1000517)
1. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
von Eyben FE; Larsen V; Pedersen H
Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
[TBL] [Abstract][Full Text] [Related]
2. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
[TBL] [Abstract][Full Text] [Related]
3. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.
Beretta G; Bonadonna G; Cascinelli N; Morabito A; Veronesi U
Cancer Treat Rep; 1976 Jan; 60(1):33-40. PubMed ID: 1000518
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
Taylor SG; Desai SA; DeWys WD
Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
[TBL] [Abstract][Full Text] [Related]
8. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
Greco FA; Richardson RL; Shulman SF; Oldham RK
Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
[No Abstract] [Full Text] [Related]
9. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
Vogl SE; Qazi R; Berenzweig M
Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea (FIVB) in colon cancer.
Falkson G; Falkson HC
Cancer Chemother Pharmacol; 1981; 6(1):31-4. PubMed ID: 7023714
[TBL] [Abstract][Full Text] [Related]
11. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
13. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
Falkson G; Pretorius HL; Falkson HC; Schoeman HS
Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy in alimentary tract malignomas.
Queisser W; Heim ME
Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
[No Abstract] [Full Text] [Related]
15. [The state of chemotherapy of colorectal neoplasms].
Hossfeld DK
Z Gastroenterol Verh; 1978; (14):97-102. PubMed ID: 88849
[No Abstract] [Full Text] [Related]
16. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
[TBL] [Abstract][Full Text] [Related]
17. DTIC (NSC-45388) studies in the southwest oncology group.
Costanzi JJ
Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
[TBL] [Abstract][Full Text] [Related]
18. Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):45-8. PubMed ID: 6837506
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies with DTIC (NSC-45388) in various malignancies.
Slavik M
Cancer Treat Rep; 1976 Feb; 60(2):213-4. PubMed ID: 769976
[No Abstract] [Full Text] [Related]
20. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]